In light of the vast economic changes in the European venture capital market as a result of the COVID-19, we started to monitor the venture sentiment more closely and highlight important findings in an aggregate index on the European level. In today’s article we take a closer look at CEE.
How is the startup community and investors doing in the midst of the Covid-19 crisis? It’s been a rather stormy ride for many over the last half-a-year and it’s far from calming down. Read on for Berthold Baurek-Karlic’s opinion, CEO of Venionare Capital, from an investor’s perspective.
Private equity (PE) funds, the larger cousins of venture capital funds, typically invest in more mature companies. In this article, we will look into the past, present and future of private equity strategies. The evolution of private equity is driven by accidentally discovered effects that our team of experts and analysts identified recently.
Our M&A team led a lighthouse M&A transaction for Blockpit, the Austrian expert for legally compliant reporting for digital asset trading to acquire its German competitor CryptoTax. With this acquisition of its biggest and larger European competitor, the company intends to drive international expansion into the US and other markets globally in 2021.
We are proud to have closed the following deals during the last weeks: Health-Tech pioneer myBioma has secured a six-figure investment from renowned investors, which was also doubled by the COVID-19 relief fund of the Austrian Promotional Bank (Die Austria Wirtschaftsservice Gesellschaft mbH – AWS) and also the award-winning RegTech platform for Business KYC (KYB), kompany has secured a follow-up funding of €6 million, which was their largest single investment round to date.
Health-tech pioneer myBioma has raised a six-figure follow-up investment from renowned investors, which is to be doubled by the COVID-19 relief fund of the AWS. The next step is for the founders to draw international attention to themselves.
Venionaire Capital enters new strategic partnership with startup300 AG in the new Dealmatrix, offering startup valuation calculator after a pivot. Beta users will foreseeably be able to use the new service from August onwards.
There are various ways to value a startup depending on their stages of development. We prepared an overview to help you distinguish between different valuation models so that you can choose the method that best fits your company or investment case.
‘The Startup Rating model by Venionaire Capital’ is a proprietary model for investors, which may be applied across different stages, without limitations of pure qualitative or financial models. The model adjusts the average valuation you have calculated or observed from the market and makes it transparent how much you should over- or underpay compared to an average valuation in order to make a fair deal.
Following the first introduction to the pre-revenue startup valuation, in this article we review the other well-known model for pre-revenue startups: the ‘Berkus Method’, named after its inventor, Dave Berkus, a well-known Californian angel investor.
Babenbergerstraße 9/12,
A-1010 Vienna, Austria (EU)
office@venionaire.com
1355 Market St. #488
San Francisco CA 94103
sfo@venionaire.com
122 East 37th Street
First Floor
New York, NY 10016
nyc@venionaire.com
Venionaire Capital exclusively invests through the European Super Angels Club, for more information and application please go to the website. We do not accept direct investment proposals via this website.